|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Jul. 16 | Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges | RE |
| Jul. 16 | Arbutus Files More Patent Infringement Suits Against Pfizer, BioNTech -- Update | DJ |
| Market Cap | 143B 125B 116B 106B 201B 13,807B 205B 1,381B 543B 6,742B 538B 526B 23,277B | P/E 2026 * |
12.8x | P/E 2027 * | 13.2x |
|---|---|---|---|---|---|
| Enterprise Value | 193B 168B 156B 143B 270B 18,557B 275B 1,857B 729B 9,062B 723B 707B 31,286B | EV / Sales 2026 * |
3.12x | EV / Sales 2027 * | 3.15x |
| Free-Float |
59.06% | Yield 2026 * |
6.86% | Yield 2027 * | 6.94% |
Last Transcript: Pfizer Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 64 | 2018-12-31 |
David Denton
DFI | Director of Finance/CFO | 60 | 2022-05-01 |
| Chief Tech/Sci/R&D Officer | - | 2006-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 68 | 2007-08-31 |
Shantanu Narayen
BRD | Director/Board Member | 62 | 2013-09-26 |
Albert Bourla
CHM | Chairman | 64 | 2019-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.08% | -3.93% | +48.03% | +160.13% | 1,031B | |
| +1.19% | -3.52% | +51.70% | +56.36% | 595B | |
| +4.21% | +1.79% | +33.48% | +87.04% | 431B | |
| +0.42% | -1.16% | +29.43% | +22.27% | 326B | |
| +1.03% | -0.84% | +29.58% | +45.08% | 277B | |
| +0.49% | -11.32% | +20.31% | +22.32% | 263B | |
| +1.59% | +3.91% | -22.47% | -36.84% | 224B | |
| +3.70% | +2.19% | +24.27% | +63.38% | 193B | |
| +3.49% | +1.08% | +24.08% | +76.58% | 164B | |
| Average | +2.01% | -1.12% | +26.49% | +55.15% | 389.37B | |
| Weighted average by Cap. | +1.81% | -2.00% | +34.66% | +79.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 61.74B 53.96B 49.91B 45.8B 86.67B 5,949B 88.18B 595B 234B 2,905B 232B 227B 10,030B | 59.2B 51.74B 47.85B 43.91B 83.11B 5,704B 84.55B 571B 224B 2,786B 222B 217B 9,617B |
| Net income | 10.63B 9.29B 8.59B 7.88B 14.92B 1,024B 15.18B 102B 40.25B 500B 39.91B 39.03B 1,726B | 10.27B 8.98B 8.3B 7.62B 14.42B 989B 14.67B 98.99B 38.89B 483B 38.56B 37.71B 1,668B |
| Net Debt | 49.3B 43.09B 39.85B 36.57B 69.21B 4,750B 70.41B 475B 187B 2,320B 185B 181B 8,009B | 43.17B 37.73B 34.9B 32.02B 60.6B 4,160B 61.66B 416B 163B 2,031B 162B 159B 7,013B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
